GlassScriptPhysician profile
Marc A Passman
NPI 1730116906
$2,307.21
in general payments reported to CMS, 2019-2025
16 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $748 · 2020: $14.67 · 2021: $31.86 · 2022: $965 · 2023: $256 · 2024: $183 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $547.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $961.46 | 2022-2023 | Endurant Iis |
| W. L. Gore & Associates, INC. | $338.89 | 2019-2025 | Gore Tag Conformable Thoracic Endoprosthesis |
| Cook Medical LLC | $325.11 | 2019-2024 | Zenith Spiral-Z |
| Medtronic Vascular, INC. | $244.85 | 2019 | |
| Bard Peripheral Vascular, INC. | $114.58 | 2019 | |
| Acera Surgical, INC. | $76.64 | 2025 | Restrata Wound Matrix |
| Silk Road Medical, INC. | $60.71 | 2019 | |
| Abbott Laboratories | $55.00 | 2022 | |
| Bolton Medical INC | $53.06 | 2023 | Treo Abdominal Stent-Graft System |
| Lemaitre Vascular, INC. | $45.10 | 2024 | Artegraft Vascular Graft |
| Boston Scientific Corporation | $18.13 | 2025 | Varithena Administration Pack |
| Tactile Systems Technology INC | $13.68 | 2019 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Passman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.